Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    Doxylamine molecular structure

    Doxylamine Stats & Data

    PubChem
    MW270.37
    FormulaC17H22N2O
    LogP2.5
    IUPACN,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
    InChIKeyHCFDWZZGGLSKEP-UHFFFAOYSA-N
    Chemical Class Aminoalkyl ether
    Psychoactive Class Depressant

    Pharmacology

    DrugBank
    Half-life 10 hours State Liquid Metabolism Hepatic.

    Description

    Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in parkinsonism.

    Mechanism of Action

    Like other antihistamines, doxylamine acts by competitively inhibiting histamine at H1 receptors. It also has substantial sedative and anticholinergic effects.

    Pharmacodynamics

    Doxylamine is an antihistamine commonly used as a sleep aid. This drug is also used to relieve symptoms of hay fever (allergic rhinitis), hives (rash or itching), and other allergic reactions. Doxylamine is a member of the ethanolamine class of antihistamines and has anti-allergy power far superior to virtually every other antihistamine on the market, with the exception of diphenhydramine (Benadryl). It is also the most powerful over-the-counter sedative available in the United States, and more sedating than many prescription hypnotics. In a study, it was found to be superior to even the barbiturate, phenobarbital for use as a sedative. Doxylamine is also a potent anticholinergic.

    Absorption

    Readily absorbed via the gastrointestinal tract.

    Indication

    Used alone as a short-term sleep aid, in combination with other drugs as a night-time cold and allergy relief drug. Also used in combination with Vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women.

    Toxicity

    PubChem DrugBank

    Toxicity associated with antihistamine use is due to overdose following oral ingestion, either unintentional or intentional suicide attempt—most commonly in young and elderly populations. Toxicity from intravenous, intramuscular, or topical routes of administration rarely occurs in the household setting. Major complications of doxylamine toxicity include arrhythmias, respiratory failure, seizures, hyperthermia, rhabdomyolysis, and coma. If the patient experiences toxicity, the healthcare team should continually monitor cardiac activity, and IV access is necessary. Like other antihistamines, doxylamine acts by competitively inhibiting histamine at H1 receptors.

    Carcinogenicity

    No indication of carcinogenicity to humans (not listed by IARC).

    Toxicity (DrugBank)

    Signs of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, swelling of face, lips, tongue, or throat.

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 3d Half tolerance 4d Baseline ~5d

    Cross-Tolerances

    Diphenhydramine
    Hydroxyzine

    Experience Report Analysis

    Erowid
    6 Reports
    2 Single-substance
    2001–2019 Date Range
    4 With Age Data

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 6 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Female 1 of 6
    • Male 5 of 6

    Age Distribution

    Reports Over Time

    Real-World Dose Distribution

    Erowid

    From 13 of 16 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Oral (n=12)

    Median: 24.0mg 25th: 12.5mg 75th: 56.25mg 90th: 97.5mg

    Form / Preparation

    Most common forms and preparations, as a share of the 5 reports that give one

    Too few reports for bars: these forms come from 5 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Pill / Tablet 2 of 5
    ← Back to Doxylamine